|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.46 EUR | -1.21% |
|
-5.55% | -8.54% |
| 11/02 | AXA : Berenberg maintains a Buy rating | ZD |
| 11/02 | European insurer stocks slide after AI concerns hit US rivals | RE |
| Capitalization | 75.07B 89.1B 68.47B 65.37B 121B 8,070B 126B 796B 316B 3,897B 334B 327B 13,620B | P/E ratio 2025 * |
8.44x | P/E ratio 2026 * | 9.25x |
|---|---|---|---|---|---|
| Enterprise value | 90.1B 107B 82.18B 78.46B 146B 9,685B 151B 956B 379B 4,677B 401B 393B 16,346B | EV / Sales 2025 * |
0.83x | EV / Sales 2026 * | 0.79x |
| Free-Float |
72.91% | Yield 2025 * |
6.2% | Yield 2026 * | 6.65% |
Last Transcript: AXA
| 1 day | -1.21% | ||
| 1 week | -5.55% | ||
| Current month | -2.52% | ||
| 1 month | -3.95% | ||
| 3 months | -3.83% | ||
| 6 months | -12.21% | ||
| Current year | -8.54% |
| 1 week | 37.28 |  | 39.82 |
| 1 month | 37.28 | | 40.27 |
| Current year | 37.28 | | 41.39 |
| 1 year | 34 | | 43.61 |
| 3 years | 24.6 | | 43.61 |
| 5 years | 19.21 | | 43.61 |
| 10 years | 11.84 | | 43.61 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Buberl
CEO | Chief Executive Officer | 52 | 01/09/2016 |
| Director of Finance/CFO | - | 01/07/2021 | |
Guillaume Borie
CTO | Chief Tech/Sci/R&D Officer | 40 | 01/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 30/04/2009 | |
Thomas Buberl
BRD | Director/Board Member | 52 | 01/09/2016 |
| Director/Board Member | 68 | 27/04/2016 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +2.88% | 1.8% | 158 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.21% | -5.55% | -1.42% | +31.90% | 89.1B | |
| -1.88% | -2.41% | +27.97% | +32.57% | 168B | |
| +0.61% | -2.27% | +7.80% | +90.75% | 62.06B | |
| +2.81% | -3.66% | +19.02% | +91.77% | 61.64B | |
| -0.84% | -1.91% | +11.20% | +66.03% | 59.6B | |
| -1.61% | -4.28% | +33.95% | +58.09% | 55.72B | |
| -0.06% | +1.22% | -5.37% | +7.30% | 50.66B | |
| +1.21% | +0.41% | +19.75% | +72.04% | 41B | |
| +0.32% | +5.56% | +20.13% | +37.82% | 38.2B | |
| +1.16% | +4.10% | +14.70% | +80.73% | 36.82B | |
| Average | +0.05% | -1.26% | +14.77% | +56.90% | 66.26B | |
| Weighted average by Cap. | -0.38% | -2.52% | +16.04% | +52.08% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 109B 130B 99.6B 95.09B 177B 11,738B 183B 1,159B 460B 5,669B 486B 476B 19,812B | 114B 135B 104B 99.32B 184B 12,260B 192B 1,210B 480B 5,921B 508B 497B 20,693B |
| Net income | 9.31B 11.05B 8.49B 8.11B 15.05B 1,001B 15.64B 98.8B 39.22B 483B 41.45B 40.6B 1,690B | 8.4B 9.97B 7.66B 7.32B 13.58B 903B 14.11B 89.14B 35.39B 436B 37.4B 36.63B 1,524B |
| Net Debt | 15.03B 17.83B 13.71B 13.08B 24.29B 1,615B 25.24B 159B 63.28B 780B 66.88B 65.5B 2,726B | 15.03B 17.83B 13.71B 13.08B 24.29B 1,615B 25.24B 159B 63.28B 780B 66.88B 65.5B 2,726B |
Employees
100,041
Sector
Life & Health Insurance
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/02/26 | 37.46 € | -1.21% | 4,520,490 |
| 12/02/26 | 37.92 € | +0.34% | 2,563,837 |
| 11/02/26 | 37.79 € | -1.74% | 3,435,709 |
| 10/02/26 | 38.46 € | -2.73% | 4,699,710 |
| 09/02/26 | 39.54 € | -0.30% | 2,400,349 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
37.46EUR
Average target price
45.11EUR
Spread / Average Target
+20.43%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CS Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition